Assessing the relative efficacy of different agents based on the outcomes from meta-analyses
2008
Concerns About Meta-Analysis of Osteoporosis Treatments
publication
Evidence: low
Author Information
Author(s): Boonen S, Vanderschueren D, Haentjens P
Primary Institution: Bone Research Unit, Leuven University Department of Experimental Medicine, Katholike Universiteit Leuven
Conclusion
The meta-analysis has major limitations and its conclusions may be misleading due to inconsistent trial selection and statistical methods.
Supporting Evidence
- The authors question the validity of the meta-analysis due to inconsistent inclusion criteria.
- Different statistical methods were used for different therapies without clear justification.
- The treatment effect of risedronate was likely underestimated due to inclusion of non-osteoporotic patients.
Takeaway
The study questions the reliability of a meta-analysis comparing osteoporosis treatments, suggesting it may not have been done properly.
Potential Biases
Potential bias due to subjective decisions in trial inclusion/exclusion and statistical methods.
Limitations
Inconsistent trial selection criteria and different statistical methods used for different therapies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website